Dialogue Health Technologies Inc.
DLHTF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $87,132 | $68,049 | $35,802 | $10,089 |
| % Growth | 28% | 90.1% | 254.9% | – |
| Cost of Goods Sold | $43,788 | $39,243 | $21,409 | $4,603 |
| Gross Profit | $43,344 | $28,807 | $14,393 | $5,486 |
| % Margin | 49.7% | 42.3% | 40.2% | 54.4% |
| R&D Expenses | $10,524 | $9,515 | $4,715 | $3,174 |
| G&A Expenses | $46,063 | $34,210 | $20,372 | $8,690 |
| SG&A Expenses | $58,790 | $45,910 | $29,805 | $14,069 |
| Sales & Mktg Exp. | $12,727 | $11,700 | $9,433 | $5,379 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $69,314 | $55,426 | $34,520 | $17,243 |
| Operating Income | -$25,970 | -$26,619 | -$20,127 | -$11,757 |
| % Margin | -29.8% | -39.1% | -56.2% | -116.5% |
| Other Income/Exp. Net | -$450 | -$225,054 | -$333 | -$286 |
| Pre-Tax Income | -$26,420 | -$251,674 | -$20,460 | -$12,043 |
| Tax Expense | -$467 | -$322 | -$229 | $0 |
| Net Income | -$25,953 | -$251,351 | -$20,231 | -$12,043 |
| % Margin | -29.8% | -369.4% | -56.5% | -119.4% |
| EPS | -0.39 | -4.48 | -0.31 | -0.19 |
| % Growth | 91.3% | -1,345.2% | -63.2% | – |
| EPS Diluted | -0.39 | -4.48 | -0.31 | -0.19 |
| Weighted Avg Shares Out | 66,136 | 56,109 | 64,878 | 64,878 |
| Weighted Avg Shares Out Dil | 66,136 | 56,109 | 64,878 | 64,878 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,233 | $753 | $295 | $162 |
| Interest Expense | $114 | $202 | $503 | $243 |
| Depreciation & Amortization | $3,552 | $2,621 | $1,921 | $703 |
| EBITDA | -$21,310 | -$249,213 | -$17,323 | -$10,929 |
| % Margin | -24.5% | -366.2% | -48.4% | -108.3% |